Found 8 matching trials
Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors PHASE2 The goal of this clinical trial is to investigate the safety and tetanus an...
Show More Learn More & Join Trial
US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease PHASE4 New immunization recommendations in the US include vaccination of adolescen...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects PHASE1 This was a dose and formulation ranging study to assess the safety and immu...
Show More Location
Multiple Locations
Treatments Being Tested
Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4 Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Learn More & Join Trial
Maternal Tdap Immunization in Guatemala PHASE2 Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and a...
Show More Location
Universidad del Valle de Guatemala
Learn More & Join Trial
A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada PHASE1 The primary objectives of this study are:
* To describe the safety profile...
Show More Location
Investigational Site Number 1240006
Learn More & Join Trial
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years PHASE1 This study will evaluate the safety and efficacy of 9 different vaccines co...
Show More Location
Center for Vaccinology (CEVAC), Ghent University Hospital
Learn More & Join Trial
Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults PHASE3 This pivotal safety trial aims to extend the safety database for BioNet rec...
Show More Status
Active Not Recruiting
Location
Chula Clinical Research Center (Chula CRC)
Learn More & Join Trial
Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) PHASE1 The purpose of this study is to evaluate the persistence of immune response...
Show More Location
Site 02, Center for Vaccinology (CEVAC), Ghent University Hospital
Learn More & Join Trial